BAMS
BLUE

Bellevue Asset Management (Switzerland)’s bluebird bio BLUE Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$1.86M Buy
2,239
+656
+41% +$655K 0.28% 86
2015
Q3 		$1.75M Buy
1,583
+39
+3% +$71.1K 0.29% 89
2015
Q2 		$3.37M Buy
1,544
+463
+43% +$943K 0.47% 67
2015
Q1 		$1.69M Buy
+1,081
New +$1.43M 0.24% 97

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s BLUE Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) increased its bluebird bio (BLUE) stake by 41% in Q4 2015, buying an estimated $655K and bringing the position to 2,239 shares worth $1.86M. The position accounts for 0.28% of the portfolio, ranked #86.

Bellevue Asset Management (Switzerland) first reported a position in BLUE in Q1 2015 and has held it in 4 quarters since. The position peaked at $3.37M in Q2 2015. 193 funds tracked by Wall St. Rank hold BLUE as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 2,239 shares of bluebird bio worth $1.86M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) bought 656 bluebird bio shares in Q4 2015, an estimated $655K.
  • bluebird bio made up 0.28% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #86 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in bluebird bio in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s bluebird bio position peaked at $3.37M in Q2 2015.
  • 193 funds tracked by Wall St. Rank held bluebird bio as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.